Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10089266rdf:typepubmed:Citationlld:pubmed
pubmed-article:10089266lifeskim:mentionsumls-concept:C0030688lld:lifeskim
pubmed-article:10089266lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10089266lifeskim:mentionsumls-concept:C0020502lld:lifeskim
pubmed-article:10089266lifeskim:mentionsumls-concept:C0006674lld:lifeskim
pubmed-article:10089266lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:10089266lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:10089266lifeskim:mentionsumls-concept:C2728259lld:lifeskim
pubmed-article:10089266pubmed:issue2lld:pubmed
pubmed-article:10089266pubmed:dateCreated1999-5-25lld:pubmed
pubmed-article:10089266pubmed:abstractTextThe treatment of patients with hyperparathyroidism provides a challenge for the dialysis team. Interventions with calcitriol therapy, phosphate binders, motivational efforts, and education on diet and renal osteodystrophy can help to control parathyroid hormone (PTH). Effects of intervention were studied on 54 hemodialysis patients for 1 year, resulting in improved outcomes.lld:pubmed
pubmed-article:10089266pubmed:languageenglld:pubmed
pubmed-article:10089266pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10089266pubmed:citationSubsetIMlld:pubmed
pubmed-article:10089266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10089266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10089266pubmed:statusMEDLINElld:pubmed
pubmed-article:10089266pubmed:monthAprlld:pubmed
pubmed-article:10089266pubmed:issn1051-2276lld:pubmed
pubmed-article:10089266pubmed:authorpubmed-author:DiabAAlld:pubmed
pubmed-article:10089266pubmed:authorpubmed-author:PooleRRlld:pubmed
pubmed-article:10089266pubmed:authorpubmed-author:CAMPB JBJlld:pubmed
pubmed-article:10089266pubmed:issnTypePrintlld:pubmed
pubmed-article:10089266pubmed:volume9lld:pubmed
pubmed-article:10089266pubmed:ownerNLMlld:pubmed
pubmed-article:10089266pubmed:authorsCompleteYlld:pubmed
pubmed-article:10089266pubmed:pagination95-8lld:pubmed
pubmed-article:10089266pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:meshHeadingpubmed-meshheading:10089266...lld:pubmed
pubmed-article:10089266pubmed:year1999lld:pubmed
pubmed-article:10089266pubmed:articleTitleClinical outcome of calcitriol therapy and patient education program on hyperparathyroidism.lld:pubmed
pubmed-article:10089266pubmed:affiliationGambro Healthcare, Orangeburg, SC 29118, USA.lld:pubmed
pubmed-article:10089266pubmed:publicationTypeJournal Articlelld:pubmed